Sabine Chlosta

Chief Medical Officer

Dr. Sabine Chlosta joined Triumvira in January 2018. Prior to Triumvira, Dr. Chlosta consulted for Aurora BioPharma, a start-up company developing CAR-T cells in solid tumors, and was previously a Senior Medical Director at Merck/MSD where she played a key role in the development of their PD-1 inhibitor Keytruda® in non-Hodgkin lymphoma and also...

Roles at Triumvira Immunologics

  • Chief Medical Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.